Baricitinib receives WHO nod for treating patients with COVID-19
by Press Release from Outbreak News Today on (#5V2E6)
NewsDesk @infectiousdiseasenews The drug baricitinib (a type of drug known as a Janus kinase (JAK) inhibitor, also used to treat rheumatoid arthritis) is strongly recommended for patients with severe or critical covid-19 in combination with corticosteroids, says a WHO Guideline Development Group of international experts in The BMJ Thursday. Their strong recommendation is based on moderate certainty [...]
The post Baricitinib receives WHO nod for treating patients with COVID-19 appeared first on Outbreak News Today.